• February 21, 2019
• 0

Pfizer and Eli Lilly have revealed more positive results for their non-opioid pain drug tanezumab - with significant improvements in chronic lower pack pain (CBLP). The results come from a phase III...

• February 21, 2019
• 0

Pfizer has won European Commission approval for its Avastin biosimilar Zirabev (bevacizumab). The approval comes on the back of data from the phase III REFLECTIONS B739-03 clinical comparative study which...